Cannabis Biotech Complex Project Receives the Green Light from Regional Government Services Committee
Alliance Growers Corp.
Pharmagreen submitted its proposal for the construction of the 62,000 square foot Cannabis Biotech Centre, a facility designed for the production of cannabis tissue cultured starter plantlets. The Biotech Centre is the primary component of the Biotech Complex, being developed on a 26-acre parcel of land in Deroche, B.C., Canada. The proposal now goes to the Fraser Valley Regional District Planning Board later this month for ratification of the Services Committee recommendation to allow the project to move forward to the permitting stage.
Alliance Growers is also pleased to report that the application to Health Canada pertaining to the Cannabis Biotech Centre that was submitted in June of 2018 for its Access to Cannabis for Medical Purposes Regulations (ACMPR) license is currently at the review stage. Pharmagreen and Alliance continue to work together in identifying capital and other resources to advance the Biotech Complex, while simultaneously developing a future customer base.
Commenting on Alliance Growers’ progress, Dennis Petke, President and CEO, stated, “We are very pleased to see the continuous advancements toward the building and ultimate completion of the Cannabis Biotech Complex, such as the latest development, being the ‘green light’ given to initiate the permit application process to begin construction. We are also pleased with the strong demand for our recently announced private placement which will be closing in multiple tranches over the next two weeks. The proceeds are being used primarily to advance our interest in the Cannabis Biotech Complex and to begin the build out of the Biocannatech facility in Montreal, thus advancing the ACMPR application. This funding round is pivotal to the Company’s move to the next level, confirming to investors that Alliance is executing on the development of its primary projects, in a timely manner. Additional financings will be completed in October, November and December of 2018, allowing Alliance to execute on its business plan, balancing the requirement for capital with the appropriate level of dilution.”
About Alliance Growers Corp.
Alliance Growers is a Diversified Global Medical Cannabis Company driven by the Company’s ‘Four Pillars’ Organization Plan — Cannabis Biotech Complex, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Technology.
Alliance Growers is working with Pharmagreen Biotech Inc. advancing a new business partnership, to jointly develop and operate a 62,000-square foot facility, to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Biotech Complex’s main facility is the Cannabis Biotech Centre which will grow Cannabis plantlets using proprietary tissue culture propagation, specifically utilizing the “Chibafreen Invitro Plant Production System”, which allows for more tissue cultured plantlets to be produced in less space and less time.
About Pharmagreen Biotech, Inc. and WFS Pharmagreen Inc.
WFS Pharmagreen Inc. is a wholly owned Canadian based subsidiary of Pharmagreen Biotech, Inc., a publicly traded company. WFS Pharmagreen Inc. is a cannabis company that is becoming the largest producer of cannabis plantlets through a proprietary tissue culture process with opportunity to become one of the largest players globally. Pharmagreen’s mission is to advance the technology of tissue culture science and to provide the highest quality 100% germ free, disease free and all genetically the same plantlets of cannabis and other flora while offering full spectrum DNA testing for plant identification, live genetics preservation using low temperature storage for various cannabis and horticulture plants; extraction of botanical oils mainly CBD oil, and to deliver laboratory based services to the North American Cannabis and agriculture sectors. For further information on the company progress on the construction of a 62,000 square foot “Cannabis Biotech Complex” please visit www.pharmagreen.ca.
In the interest of full disclosure, we call the reader’s attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.
Read Next
